Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic autoinflammatory syndrome with immune deficiency characterized by a combination of autoinflammation, immunodeficiency, and neutrophil dysfunction, as well as mild bleeding diathesis. Patients present recurrent attacks of abdominal pain, high fever, and systemic inflammation lasting four to five days and occurring every few weeks. Attacks may be accompanied by nailbed, tongue, submandibular, and gluteal abscesses, intra-abdominal granulomas, pyoderma gangrenosum, and buccal ulcerations. Frequent episodes of purulent paronychia, superficial skin and mucosal infections, and purulent upper respiratory tract infections have also been reported.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome.
201 publications have been identified in PubMed for CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome. Kisho has analyzed 28 by research type. Research spans Review / Meta-Analysis (71%), Other (11%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 20 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:21 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome
Other research | 3 | 11% |
Disease patterns and progression | 3 | 11% |
Patient case studies | 2 | 7% |
Kaul A (2025). [PMID: 40915300](https://pubmed.ncbi.nlm.nih.gov/40915300/). *Lancet Rheumatol*. [Review / Meta-Analysis]
Merendino A (2025). [PMID: 40080340](https://pubmed.ncbi.nlm.nih.gov/40080340/). *Eur Geriatr Med*. [Review / Meta-Analysis]
Martellucci S (2025). [PMID: 40307983](https://pubmed.ncbi.nlm.nih.gov/40307983/). *Otol Neurotol*. [Case Report / Case Series]
Sun XF (2025). [PMID: 39824181](https://pubmed.ncbi.nlm.nih.gov/39824181/). *Med*. [Epidemiology / Natural History]
Menart AC (2025). [PMID: 40195582](https://pubmed.ncbi.nlm.nih.gov/40195582/). *J Gerontol A Biol Sci Med Sci*. [Epidemiology / Natural History]
Odusanya BO (2025). [PMID: 38486122](https://pubmed.ncbi.nlm.nih.gov/38486122/). *Int J Impot Res*. [Review / Meta-Analysis]
Castagna F (2025). [PMID: 40466258](https://pubmed.ncbi.nlm.nih.gov/40466258/). *JACC Heart Fail*. [Review / Meta-Analysis]
Dotan A (2025). [PMID: 39931017](https://pubmed.ncbi.nlm.nih.gov/39931017/). *Harefuah*. [Review / Meta-Analysis]
Dwivedi P (2025). [PMID: 41026272](https://pubmed.ncbi.nlm.nih.gov/41026272/). *J Clin Immunol*. [Other]
Olivé-Arias O (2025). [PMID: 40812939](https://pubmed.ncbi.nlm.nih.gov/40812939/). *Rev Colomb Psiquiatr (Engl Ed)*. [Review / Meta-Analysis]